EMMA News and Press, Emmaus Life Sciences Incorporation From 08/14/23

2023-08-14 17:28:16 ET Emmaus Life Sciences press release ( OTCQX:EMMA ): Q2 GAAP EPS of -$0.03. Revenue of $10.8M (+152.3% Y/Y). For further details see: Emmaus Life Sciences GAAP EPS of -$0.03, revenue of $10.8M

Emmaus Life Sciences Reports Q2 2023 Financial Results PR Newswire Record Net Revenues Contributed to Income from Operations Sixth Straight Quarterly Increase in Net Revenues TORRANCE, Calif. , Aug. 14, 2023 /PRNewswire/ -- Emmaus Life Sciences,...

Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman PR Newswire Sickle Cell Disease Treatment Commercially Available in Five GCC Countries TORRANCE, Calif. , July 13, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA)...

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA PR Newswire TORRANCE, Calif. , May 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that...

2023-05-16 04:11:46 ET Emmaus Life Sciences press release ( OTCQX:EMMA ): Q1 GAAP EPS of -$0.07. Revenue of $6.8M (+110.5% Y/Y) beats by $1.8M . On March 31, 2023, the company had cash and cash equivalents of $1.8 million, compared with $2.0 million on December 31, 202...

2023-05-15 10:52:34 ET Those afflicted with sickle cell disease face many challenges and acute complications. This %Biopharma company is the leader in treatment of the disease and just reported its fifth straight increase in quarterly net revenues. %EmmausLifeSciences (OTC: $EMM...

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update PR Newswire TORRANCE, Calif. , May 15, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treat...

Emmaus Life Sciences Provides Interim Shipment Data PR Newswire TORRANCE, Calif. , April 3, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) , a leader in sickle ell disease treatment, announced today preliminary results for the 3 months ended ...

2023-04-03 01:09:23 ET Emmaus Life Sciences press release ( OTCQX:EMMA ): FY GAAP EPS of -$0.21. Revenue of $18.39M (-10.8% Y/Y). For further details see: Emmaus Life Sciences GAAP EPS of -$0.21, revenue of $18.39M

Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update PR Newswire TORRANCE, Calif. , March 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) , a commercial-stage biopharmaceutical company and leader in the treat...